Potential advantages of loco-regional intra-arterial chemotherapy

In Vivo

Volumn 20, Issue 6 A, 2006, Pages 777-780

  Cagol, Pier Paolo ^a   Pasqual, Enricomaria ^a   Bacchetti, Stefano ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Hepatic infusion; Intra arterial chemotherapy; Liver metastases; Locoregional treatments

Indexed keywords

CISPLATIN; EPIRUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG LIVER LEVEL; DRUG TUMOR LEVEL; EXPERIMENTAL NEOPLASM; HEPATIC ARTERY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER METASTASIS; NONHUMAN; RAT;

EID: 33846100103     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Healy JE: Vascular patterns in human metastatic liver tumours. Surg Gynecol Obstet 120: 1187-1193, 1965.
2. Ackerman NB, Lien WM, Xondi ES, and Silverman NA: The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumours. Surgery 66: 1067-1072, 1969.
3. Cagol PP, Da Plan PP, Miotto D, Pilati PL, Pasqual EM, Talenti E and Lise M: Vascularization of experimental liver metastases. 1 Blood supply and vascular patterns. J Exp Clin Cancer Res 8: 113-122, 1989.
4. Chen GSH and Gross JF: Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Reports 64: 31-40, 1980.
5. Ensminger WD and Gyves JW: Clinical pharmacology of hepatic arterial chemotherapy. Sem Oncol 10: 176-182, 1983.
6. Collins JM: Pharmacological rationale for hepatic arterial therapy. Recent Results in Cancer Research 100: 140-147, 1986.
7. Van De Velde CJH, De Brauw LM, Sugarbaker PH and Tranberg G: Hepatic artery infusion chemotherapy: rationale, results, credits and debits. Reg Cancer Treat 1: 93-101, 1988.
8. Pasqual EM, Da Pian PP, Pilati PL, Andriulo B, Ishak-Waris K, Orsini C, Prevaldi C and Cagol PP: Induzione di metastasi epatiche di Walker carcinoma 256 nel ratto. Messa a punto del modello sperimentale. Atti X Congresso Nazionale S.I.C.O. - Cefalu' (Palermo). Bologna: Monduzzi, 559-562, 1986.
9. Camaggi CM, Strocchi E, Tamassia V, Martoni A, Giovannini M, Infelice G, Canova N, Marraro D, Martini A and Pannuti F: Pharmacokinetic study of 4'epidoxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat Rep 66: 295-301, 1985
10. Cagol PP, Pasqual EM, Prevaldi C, Mazzier M, Digito F, Civalleri D, Arslan P, Beltrame M and Nicolini M: Does Hyaluronidase increase CDDP level within experimental intraabdominal tumors after intracavity administration? J Exp Clin Cancer Res 10: 253-258, 1991.
11. De Brauw LM, Van De Velde CJH, Tjaden UR, De Bruijn EA, Bell AVRJ, Hermans J and Zwaveling A: In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-Fluorouracil concentrations in tumour tissue. J Surg Res 44: 137-145, 1988.
12. Pohlen U, Reszka R, Schneider P, Buhr HJ and Berger G: Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumour-bearing rabbits. Anticancer Res 24: 1699-704, 2004.
13. Butler JA, Trezona TP, Nordestgaard A and State D: Hepatic artery versus portal vein and systemic infusion of Fluorodeo-xiuridine of rabbit VX-2 hepatic implants. Am J Surg 157: 126-129, 1989.
14. Lee YTM, Chan KK and Harris PA: Tissue disposition of doxorubicin in experimental animals. Med Ped Oncol 10: 259-267, 1982.
15. Ridge JA, Collin C, Bading JR, Hancock C, Conti PS, Daly JM and Raaf JH: Increased adriamycin levels in hepatic implants of rabbit Vx-2 carcinoma from regional infusion. Cancer Res 48(16): 4584-4587, 1988.
16. Sileni VC, Fosser V, Maggian P, Padula E, Beltrame M, Nicolini M and Arslan P: Pharmacokinetics and tumour concentration of intraarterial and intravenous cisplatin in patients with head and neck squamous cancer. Cancer Chemother Pharmacol 30(3): 221-225, 1992.
17. Fiorentini G, Rossi S, Dentico P, Meucci F, Bonechi F, Bernardeschi P, Cantore M, Guadagni S and De Simone M: Oxaliplatin Hepatic Arterial Infusion Chemotherapy for Hepatic Metastases from Colorectal Cancer: Anticancer Res 24: 2093-2096, 2004.
18. Pohlen U, Mansmann U, Berger G, Germer CT, Gallkowski U, Boese-Landgraf J and Buhr HJ: Multicenter Pilot Study of 5-Fluorouracil, Folinic Acid, Interferon Alpha-2b and Degradable Starch Microspheres Via Hepatic Arterial Infusion in Patients with Nonresectable Colorectal Liver Metastases. Anticancer Res 24: 3275-3282, 2004.
19. Kato Y, Tsuyuki A, Kikuchi K, Tokuyama J, Kurihara N, Kumamoto Y, Fujishiro Y and Ebinuma H: Continuous Hepatic Arterial Infusion Chemotherapy for Liver Metastasis from Biliary Tract and Pancreatic Cancers. Anticancer Res 25: 477-482, 2005.
20. Wang P, Chen Z, Huang WX and Liu LM: Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: A literature review of randomized control trials. World J Gastroenterol 11(25): 3817-3822, 2005.